Menu

Back to Medication Guide

Upadacitinib

Generic Name: Upadacitinib

Brand Names: Rinvoq

Upadacitinib is a selective JAK1 inhibitor for multiple inflammatory conditions including RA, psoriatic arthritis, and atopic dermatitis.

RheumatologicDermatologicGastrointestinalJAK Inhibitor

What It's Used For

Side Effects

Common side effects:

  • Upper respiratory infections
  • Nausea
  • Cough
  • Fever
  • Acne

Serious side effects (boxed warnings apply):

  • Serious infections
  • Malignancy
  • Thrombosis
  • Cardiovascular events

Additional Information

What is Upadacitinib?

Upadacitinib is a selective JAK1 inhibitor with high efficacy across multiple conditions.

Selectivity

More selective for JAK1 than older JAK inhibitors, though clinical significance of this selectivity is debated.

Wide Approval

Approved for more conditions than other JAK inhibitors.

For more information, see MedlinePlus.

Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with your healthcare provider before starting, stopping, or changing any medication. Your doctor can provide personalized recommendations based on your specific health condition and medical history.

Loading questions...

Ask Dr. Zimmer

Have questions about Upadacitinib? Get expert answers from Dr. Zimmer.

Privacy: Your questions are posted anonymously for your health privacy. Your name and email are only used for admin purposes.

Questions are reviewed before posting. You'll see your question and Dr. Zimmer's answer below once approved.